Friday - January 30, 2026
Ahead Therapeutics Awarded Breakthrough T1D IDDP Grant to Accelerate ASIT Platform Technology Development for Type 1 Diabetes
January 29, 2026
NEW YORK, Jan. 29 -- Breakthrough T1D (formerly JDRF) a non-profit dedicated to funding type 1 diabetes research, posted the following news release:

* * *

Ahead Therapeutics Awarded Breakthrough T1D IDDP Grant to Accelerate ASIT Platform Technology Development for Type 1 Diabetes

*

BARCELONA, Jan. 29, 2026 -Ahead Therapeutics, a Spanish biotechnology company focused on transformative solutions for autoimmune diseases, today announced it has bee . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products